Determinants of Brain Metastasis Development and Survival in Breast Cancer Patients: Insights from a Multi-Center Study - Top-Institutions - MDSpire

Determinants of Brain Metastasis Development and Survival in Breast Cancer Patients: Insights from a Multi-Center Study

  • By

  • Ahmad Alhalabi

  • Theresa Abdo

  • Ali Hijazi

  • Mohamed Mohanna

  • Rami Tfayli

  • María Herrán

  • Saad Sabbagh

  • Saffet Guleryuz

  • Razan Mohanna

  • Rashid Mahrous

  • Kaylee Sarna

  • Surabhi Ranjan

  • Christopher W Fleming

  • Zeina Nahleh

  • December 19, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Breast Cancer
    • Radiation Oncology
    • Medical Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Neuro-oncology
    • Breast Cancer Research

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-oncology
    • Breast Cancer
    • Radiation Oncology

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Neuro-oncology
    • Breast Cancer
    • Clinical Research

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neuro-oncology
    • Breast Cancer
    • Translational Research

Original Source(s)

Determinants of Brain Metastasis Development and Survival in Breast Cancer Patients: Insights from a Multi-Center Study

  • by Ahmad Alhalabi, Theresa Abdo, Ali Hijazi, Mohamed Mohanna, Rami Tfayli, María Herrán, Saad Sabbagh, Saffet Guleryuz, Razan Mohanna, Rashid Mahrous, Kaylee Sarna, Surabhi Ranjan, Christopher W Fleming, Zeina Nahleh

  • December 19, 2025

Related Content

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer